Inc. has recently rebranded as Deinium Therapeutics Inc., is changing its Nasdaq ticker to DFTX, and outlined a late-stage ...

Detailed price information for Incannex Healthcare Inc ADR (IXHL-Q) from The Globe and Mail including charting and trades.

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

The year 2025 was a defining one for Incannex,” stated Joel Latham, Incannex Healthcare Chief Executive Officer. “We delivered two independent, positive Phase 2 clinical readouts across distinct CNS ...

Menopausal hormone replacement therapy (MHT) was once routinely used to relieve symptoms of menopause and protect against ...

January can be quite a depressing month, because of the weather or the post-holiday blues, and it’s a month many look forward ...

Surgery for refractory constipation should be a last resort, used only after comprehensive physiologic and psychological ...

January 15, 2026 / A subtle but important change is underway in how SMX (NASDAQ:SMX) is being evaluated by the market. The ...

Applied Digital (APLD) is restructuring by spinning out its cloud segment, ChronoScale, retaining 97% ownership, and ...

Mind Medicine has altered its state, rebranding as Definium Therapeutics ahead of a series of phase 3 data drops on its lead ...

Regeneron's strategy focuses on a broad pipeline across six therapeutic areas, with significant near-term data readouts ...

Wayne State University researchers are getting major grant support to study the possible therapeutic benefits of cannabis for ...